Eilers and Nocilly Elected to MedTech Board of Directors
Monday, October 19, 2009
Syracuse, NY – David Eilers, vice president of business development at Blue Highway and David Nocilly, partner, Bond Schoeneck & King, PLLC, were elected to the board of directors at MedTech, a trade association representing the Upstate New York biosciences community at MEDTECH 09, theassociation’s annual conference, last week.
"My interest in joining the MedTech Board of Directors is to be a catalyst for enhanced innovation activity,” said Eilers. “That means reaching out to the start-up community and providing avenues for development and commercialization-- as well as being a liaison between emerging enterprises and well established corporations.”
Throughout his 25 year career, Eilers has been a goal-oriented enterprise leader who enjoys pioneering new products as well as opening new markets worldwide. For the last decade, he has been employed in the healthcare industry working as both a consultant and in management. Eilers’ current interest is applying an open innovation business model to diagnostic healthcare-- bridging the gap between invention and market introduction.
"I’m really excited to be a part of MedTech” said Nocilly. “I look forward to implementing our goal of promoting the upstate New York region as a nationally recognized center for biosciences,” he said.
Nocilly has been a member of MedTech since 2004. He is a registered patent attorney who has prepared and prosecuted numerous patent applications for electromechanical, biomedical, and mechanical inventions. Nocilly also handles the enforcement of the full range of intellectual property rights. Nocilly is a graduate of Cornell University and received his J.D. summa cum laude from Syracuse University College of Law.
Eilers’ two-year term as a director on MedTech’s Board will run until the fall of 2011. Nocilly’s term will end in the fall of 2010. Mitch Katz, partner, Mentor Rudin & Trivelpiece and Richard Cauchon, corporate initiatives, Sensis Corporation have also been re-elected to the board. Cauchon will serve for two more years and Katz will serve for one.
MedTech is a not-for-profit trade association comprised of Upstate New York technology manufacturers, research institutions, and allied professional services and economic development organizations. We promote the commercialization of medical products by providing educational and networking events, organizing certification opportunities, and facilitating collaborations among members to bring tomorrow’s technologies to the health care marketplace. For more information, visit www.medtech.org.